A veteran biostatistician on the planning document and the dose-selection shortcut that quietly decide whether trials succeed.
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why eSource: The Advantages of Abandoning Paper Records
Eliminate transcription errors and fully leverage supporting eClinical technology to provide a reliable consistent exchange of information.
-
Enhancing Oncology Trials With Clinical Platform Solutions
This example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.
-
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them
Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
Maximize The Value Of Wearable Data
Explore this near real-time adherence monitoring solution for clinical trial sponsors that compares wearable device data collected from a participant's scheduled activities and visit dates.
-
Trends In Clinical Trials In 2025: Navigating A Transformative Landscape
In 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears Fast
Discover how to maintain strategic leverage during vendor selection. Learn to identify flexible, long-term partners who keep clinical trials on track before contracts are signed.
-
FDA Releases Updated Draft Guidance On Decentralized Clinical Trials
Take a closer look at the FDA's draft guidance on designing and implementing DCTs, notably remote trial visits, the use of digital health technologies, institutional review board oversight, and more.
-
Clinical Trial Budgeting Faces Pressure To Modernize
Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.
-
Veeva Vault EDC Features Brief
Delve into the details of how Veeva Vault EDC, a cutting-edge cloud-based EDC solution, enables users to design and execute their studies 50% faster with 50% less effort.
RECENT NEWSLETTERS
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build